Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05384119
Title Phase 1b/2 Study of TTI-101 in Combination for Patients With Metastatic Hormone Receptor-Positive and HER2-Negative Breast Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Tvardi Therapeutics, Incorporated
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Holy Cross Health Fort Lauderdale - Holy Cross Hospital Fort Lauderdale Florida 33308 United States Details
Washington University School of Medicine Siteman Cancer Center Saint Louis Missouri 63110 United States Details
Vanderbilt - Ingram Cancer Center Nashville Tennessee 37232 United States Details
Texas Oncology - Dallas Fort Worth (DFW) - Baylor Charles A. Sammons Cancer Center Dallas Texas 75246 United States Details
Harold C. Simmons Comprehensive Cancer Center Dallas Texas 75390 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from for the field